US2012238916A1PendingUtilityA1
Ultrasound catheter and methods for making and using same
Est. expiryJan 14, 2023(expired)· nominal 20-yr term from priority
A61M 25/001A61B 2017/003A61M 25/0009A61B 2017/22015A61B 2017/22014A61B 2017/00292A61B 2017/00526A61B 2017/22011A61B 2017/00154A61B 17/22012A61B 2017/00331A61B 2017/00141A61M 25/0041A61B 2017/320072
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Ultrasound catheter devices and methods provide enhanced disruption of blood vessel obstructions. Generally, ultrasound catheters include an elongate flexible catheter body with one or more lumens, an ultrasound transmission member extending longitudinally through the catheter body lumen and, in some embodiments, a guidewire tube extending through the lumen. A distal head for disrupting occlusions is coupled with the distal end of the ultrasound transmission member and is positioned adjacent the distal end of the catheter body. Some embodiments include improved features such as a bend in the catheter body for enhancing positioning and/or advancement of the catheter.
Claims
exact text as granted — not AI-modified1 . A method for treating an occlusion in an artery comprising:
performing a procedure at a treatment area; applying endovascular ultrasound energy at the treatment area to enhance the vessel permeability; positioning a device around the treatment area; and delivering a medicament in mixture with a dye.
2 . The method of claim 1 , wherein the procedure is an ultrasound angioplasty.
3 . The method of claim 1 , wherein the therapeutic agent is delivered to the treatment area while ultrasound energy is applied.
4 . The method of claim 1 , wherein the frequency of the ultrasonic energy is at least 20 kHz.
5 . The method of claim 1 , wherein the ultrasound energy is applied using an ultrasound catheter having a proximal transducer that is located outside the body.
6 . The method of claim 1 , wherein the ultrasound energy is delivered using an ultrasound catheter having a transducer coupled to a proximal end of the catheter.
7 . The method of claim 1 , further comprising positioning a sheath over the device using one of the following methods: distally to the treatment area, proximally to the treatment area or combination of both.
8 . The method of claim 1 , wherein the device is an ultrasound catheter.
9 . The method of claim 1 , wherein the mixture of medicament and dye remains in the treatment area of the artery for a period of time.
10 . The method of claim 1 , further comprising delivering a mixture of medicament, dye, and saline.
11 . The method of claim 1 , wherein the therapeutic agent is oxygenated.
12 . The method of claim 1 , wherein treating an occlusion in an artery involves treating a totally occluded artery.
13 . A method for treating an occlusion in an artery comprising:
applying endovascular ultrasound energy to a treatment area to enhance the vessel permeability; positioning a device within the treatment area; and delivering a medicament in mixture with a dye.
14 . A method for treating chronic total occlusion in an artery comprising:
performing an endovascular ultrasound procedure at a treatment area; and delivering a medicament to the treatment area.
15 . A method of claim 14 , wherein the medicament is delivered during an ultrasound angioplasty.
16 . A method of claim 14 , wherein the medicament is delivered in a mixture with saline.
17 . A method for treating an occlusion in an artery comprising:
performing an ultrasound angioplasty at a treatment area; applying endovascular ultrasound energy at the treatment area to enhance the vessel permeability; and delivering a medicament to the treatment area.
18 . A method of claim 17 , wherein a mixture of therapeutic agent and irrigation fluid is delivered using one of the following methods: during angioplasty, after angioplasty or combination of both.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.